Delphine Le Louet
Stock Analyst at Bernstein
(0.44)
# 4,408
Out of 5,055 analysts
181
Total ratings
43.4%
Success rate
-6%
Average return
Main Sectors:
Stocks Rated by Delphine Le Louet
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EPA: ERF Eurofins Scientific SE | Downgraded: Hold | €53.80 → €73.90 | €77.86 | -5.09% | 8 | Sep 29, 2026 | |
| AMS: LKFT Lakefront Biotherapeutics NV | Reiterated: Hold | €27.90 | €26.04 | +7.14% | 3 | Sep 1, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Reiterated: Buy | €284.00 → €273.00 | €258.00 | +5.81% | 22 | Jul 30, 2026 | |
| ETR: GXI Gerresheimer AG | Reiterated: Hold | €28.70 | €29.48 | -2.65% | 15 | Jul 29, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Reiterated: Buy | €234.00 → €230.00 | €216.40 | +6.28% | 15 | Jul 28, 2026 | |
| SWX: TECN Tecan Group AG | Upgraded: Hold | CHF 165.20 → CHF 156.00 | CHF 247.00 | -36.84% | 2 | Jan 16, 2026 | |
| STO: GETI.B Getinge AB (publ) | Initiated Coverage: Hold | kr 228.00 | kr 256.80 | n/a | 1 | Jun 17, 2025 | |
| EPA: DBV DBV Technologies S.A. | Reiterated: Buy | €5.70 → €3.03 | €1.60 | n/a | 10 | Mar 17, 2024 | |
| SWX: ALC Alcon Inc. | Reiterated: Hold | CHF 77.60 → CHF 72.20 | CHF 53.38 | n/a | 16 | Feb 29, 2024 | |
| EPA: IPN Ipsen S.A. | Reiterated: Buy | €142.00 → €150.40 | €145.60 | n/a | 14 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €20.30 → €13.60 | €2.67 | n/a | 9 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €57.00 → €57.10 | €40.07 | n/a | 7 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €20.10 → €18.95 | €22.47 | n/a | 12 | Oct 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €186.40 → €189.80 | €148.10 | n/a | 19 | Oct 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €103.00 → €101.00 | €85.65 | n/a | 15 | Sep 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $25.00 | n/a | 2 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | €579.00 → €612.00 | €205.50 | n/a | 6 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $12 | $8.87 | n/a | 4 | May 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $142 | $82.55 | n/a | 1 | Oct 8, 2020 |
Eurofins Scientific SE
Sep 29, 2026
Downgraded: Hold
Price Target: €53.80 → €73.90
Current: €77.86
Upside: -5.09%
Lakefront Biotherapeutics NV
Sep 1, 2026
Reiterated: Hold
Price Target: €27.90
Current: €26.04
Upside: +7.14%
Sartorius Aktiengesellschaft
Jul 30, 2026
Reiterated: Buy
Price Target: €284.00 → €273.00
Current: €258.00
Upside: +5.81%
Gerresheimer AG
Jul 29, 2026
Reiterated: Hold
Price Target: €28.70
Current: €29.48
Upside: -2.65%
Sartorius Stedim Biotech S.A.
Jul 28, 2026
Reiterated: Buy
Price Target: €234.00 → €230.00
Current: €216.40
Upside: +6.28%
Tecan Group AG
Jan 16, 2026
Upgraded: Hold
Price Target: CHF 165.20 → CHF 156.00
Current: CHF 247.00
Upside: -36.84%
Getinge AB (publ)
Jun 17, 2025
Initiated Coverage: Hold
Price Target: kr 228.00
Current: kr 256.80
Upside: n/a
DBV Technologies S.A.
Mar 17, 2024
Reiterated: Buy
Price Target: €5.70 → €3.03
Current: €1.60
Upside: n/a
Alcon Inc.
Feb 29, 2024
Reiterated: Hold
Price Target: CHF 77.60 → CHF 72.20
Current: CHF 53.38
Upside: n/a
Ipsen S.A.
Jan 3, 2024
Reiterated: Buy
Price Target: €142.00 → €150.40
Current: €145.60
Upside: n/a
Dec 22, 2023
Reiterated: Buy
Price Target: €20.30 → €13.60
Current: €2.67
Upside: n/a
Nov 13, 2023
Reiterated: Buy
Price Target: €57.00 → €57.10
Current: €40.07
Upside: n/a
Oct 24, 2023
Reiterated: Hold
Price Target: €20.10 → €18.95
Current: €22.47
Upside: n/a
Oct 20, 2023
Upgraded: Buy
Price Target: €186.40 → €189.80
Current: €148.10
Upside: n/a
Sep 29, 2023
Reiterated: Hold
Price Target: €103.00 → €101.00
Current: €85.65
Upside: n/a
Oct 13, 2022
Downgraded: Hold
Price Target: n/a
Current: $25.00
Upside: n/a
Jan 28, 2022
Upgraded: Buy
Price Target: €579.00 → €612.00
Current: €205.50
Upside: n/a
May 4, 2021
Upgraded: Hold
Price Target: $12
Current: $8.87
Upside: n/a
Oct 8, 2020
Upgraded: Hold
Price Target: $142
Current: $82.55
Upside: n/a